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Abstract
The metabolic phenotype varies widely due to external factors such as diet and gut microbiome composition, among
others. Despite these temporal fluctuations, urine metabolite profiling studies have suggested that there are highly
individual phenotypes that persist over extended periods of time. This hypothesis was tested by analyzing the exhaled
breath of a group of subjects during nine days by mass spectrometry. Consistent with previous metabolomic studies based
on urine, we conclude that individual signatures of breath composition exist. The confirmation of the existence of stable
and specific breathprints may contribute to strengthen the inclusion of breath as a biofluid of choice in metabolomic
studies. In addition, the fact that the method is rapid and totally non-invasive, yet individualized profiles can be tracked,
makes it an appealing approach.
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Introduction
Personalized medicine aims to tailor medical treatment to the
individual characteristics of each patient [1]. With the advent of
high-throughput genome sequencing techniques, the concept of
personalized health care is about to become a reality in the clinic
[2]. However, the genome alone cannot account for factors like life
style, interplay with gut microbiome [3] or circadian cycle [4–6].
For this reason, mapping of the metabolome and relating it to sub-
populations or even individuals will be critical to fully achieve the
concept of personalized healthcare [7]. However, precisely
because the metabolome accounts for external factors, it is subject
to intra-individual variations that need to be characterized. To
address this issue, recent studies have investigated the question
whether individual metabolic phenotypes are stable during
extended periods of time [8,9].
As other biofluids, breath contains relevant biochemical
information, since it carries a large fraction of the most volatile
metabolites [10]. Breath analysis is completely non-invasive, and
therefore an attractive approach, which in principle is also suitable
to monitor an individual’s health status over extended periods of
time. However, breath analysis has not yet been routinely used to
complement the analysis of other biofluids in order to contribute to
an individualized healthcare. This situation may start to be
reversed by the assessment of the intra-individual variations of the
composition of human breath; and ultimately examining whether
or not individualized breathprints persist over the time. This has
been the main goal of the present study.
Materials and Methods
Subjects
Eleven subjects [6 males/5 females; age 29.864.6 years (mean
6 SD)] were included in this study. The subjects were ETH staff
with a heterogeneous ethnic background (see Supplementary table
S1 for details). During the period examined, the subjects did not
change their routine life style. They came to our facilities during
nine working days and their breath was analyzed during four time
slots: 8 AM–11 AM; 11 AM–1 PM; 1 PM–3 PM and 3 PM–
6 PM). Note that not all of them could attend every measurement;
therefore, the total number of samples collected per subject ranged
between 10 and 26 (average of 18). The order in which the
subjects’ breath was analyzed was randomized. To minimize
confounding effects, the participants refrained from eating,
drinking and brushing their teeth at least 30 minutes prior to
the measurements. None of the subjects was a smoker and their
routine dietary habits were kept constant. The Research Ethics
Committee of ETH Zurich approved the study (EK 2012-N-25),
and all subjects gave written informed consent to participate.
Mass spectrometric analyses
The participants were asked to breathe through a heated Teflon
tube (3 mm i.d.) connected to the curtain gas port of a quadrupole
time-of-flight mass spectrometer (Q-TOF Ultima, Waters Inc.).
The sampling tube was surrounded with a heating tape at 90 uC to
prevent water condensation and to minimize losses onto the walls
of exhaled compounds. Each time, a subject provided a full
exhalation, while keeping the pressure through the sampling line at
20 mbar (typically +/2 2mbar;monitored by a digital manometer;
this translated to a flow rate of 3.8 L/min). This process was
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performed in triplicate. The exhaled breath encountered an
electrospray plume, where some compounds get ionized and
subsequently are mass analyzed. This technique has been referred
to as secondary electrospray ionization (SESI) [11]. The spray was
formed with a home built source by infusing water (0.2% formic
acid) at ,100 nL/min through a PicoTip emitter (20 i.d; 360 o.d.)
held at 2 kV (,400 nA) above the sampling orifice. The
electrospray tip was located 6 mm from the sampling cone and
1 mm off the symmetry axis.
Data analysis
The three replicate mass spectra of each sample were averaged
with MassLynx (Waters) and exported as txt files (m/z-intensity
pairs). In this process, only the last few seconds (typically around
6 sec.) of each exhalation was considered, excluding from the
analysis the first part of the exhalation which reflects mostly the
dead volume in the upper respiratory tract. Further analysis was
conducted with Matlab (R2011b, Mathworks Inc.). The original
mass spectra were interpolated to 10,000 m/z values (56–400 Da,
in steps of 0.0187 Da). The spectra were normalized by
standardizing the area under the curve to the total median. After
individually normalizing every signal, they were further scaled to
adjust the overall maximum intensity to 100. Finally a
193610,000 matrix was assembled.
First, we applied a Kruskal-Wallis test [12] to filter the most
informative features regarding donor-specificity. The condition to
retain an m/z value for further analysis was twofold: P,1023 and
in addition, at least one pair of measurements must be significantly
different upon a further multicomparison test (Bonferroni correct-
ed, 95% confidence level). These conditions were satisfied by
2,928 m/z signals. Further multivariate analysis to determine the
existence of individual breathprints was pursued by combination
of standard multivariate methods as previously described [8,9].
Essentially, the dimensionality of the 19362,928 matrix was
further reduced by principal component analysis (PCA) and
canonical analysis (CA). The PCA score sub-matrix (99.99% of
explained variance) was subjected to MANOVA, which as
performed by MATLAB computes CA, yielding 10 dimensions
(all with P,1023) maximizing the separation of the 11 subjects.
The interpretation of the resulting discriminant functions to
ascertain the contribution of the different mass spectral signals to
the separation between subjects, was performed by standardizing
the combined loading coefficients of PCA and CA as described
previously [13,14]. To visualize the contribution of the resulting 10
canonical dimensions to the discrimination of the subjects, they
were used as input to compute hierarchical clustering (Euclidean
distance).
Finally, the Kruskal-Wallis/PCA/CA model was cross-validat-
ed (train size = 182; test size = 11). The 11 test breath mass spectra
were projected onto the subspace generated by the 182 training
mass spectra and individually classified with a k-nearest neighbor
classifier (k = 1; Euclidean distance). This process was repeated 500
times, shuffling in each iteration the test and training samples
(Monte Carlo repartitions).
Figure 1. Real-time analysis allows for the rapid breathprinting of subjects. During the 1.5 hours experiment shown above, nine subjects
breathed into the mass spectrometer. The subjects’ label codes are indicated at the top of each of the three replicate measurements in the top trace.
The three traces correspond to the ion intensity as a function of time for m/z 59, 151 and 207. Each subject breathed in triplicate, which is illustrated
by the three steps of the signal above the background per subject. This snapshot already illustrates the high inter-subject breathprint variability.
doi:10.1371/journal.pone.0059909.g001
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Results and Discussion
SESI-MS allows for real-time breathprinting, producing rich
mass spectrometric signatures [15–19]. This is illustrated in
Figure 1, in which three examples of m/z values found in the
breath of nine of the subjects are plotted. As noted above, not all
the subjects could regularly attend every measurement. In the
particular example shown in figure 1, subjects 4 and 7 were not
present. Each trace corresponds to an ion’s intensity as a function
of time. During the 1.5 hours of the time trace shown, nine
subjects breathed into the system (subject-label code indicated with
arrows). The signal steps appearing above the background level
result from a single exhalation, and it can be appreciated how the
three replicate measurements per subject show comparable
heights. Note that it is obvious already at this stage that each
subject shows a distinct breathprint. For example, the ion at m/z
59 (acetone, based on a previous characterization [15]), is present
in all subjects’ breath, but in highest concentrations for subjects 6
and 11. This high individual variability is consistent with previous
measurements of breath acetone [20,21]. However, figure 1
constitutes just a snapshot reflecting part of the exhaled breath
composition at a given moment (morning measurement; 8 AM–
11 AM). In the present study, we sought to assess the amplitude of
the intra-individual variations reflected in fluctuations of exhaled
breath composition over the course of several days, including
intra-day measurements (i.e. morning and afternoon).
This is illustrated in Figure 2 for the three representative ions of
figure 1. The box plots provide an overview of the intra- and inter-
subject variability during the whole period. For example, acetone
(m/z 59) seems to have a greater intra-subject variability than m/z
207. This is also consistent with previous work [20], showing that
inter- and intra-subject diurnal levels of breath acetone can be
vary widely. Similarly, large variations of ethanol and acetalde-
hyde were found in a longitudinal study over a 6-month period
[22]. We further assessed whether or not intra-subject variability
were significantly different via a multicomparison (Bonferroni
corrected). The results are summarized in the right hand side
panels of figure 2, which show the computed mean ranks (95%
confidence interval). Two means are significantly different if their
intervals are disjoint, and are not significantly different if their
intervals overlap. Thus, for example, subjects 2 and 8 show
particularly low levels of these three compounds and are
significantly different of several of the other subjects. The rest of
the subjects show overlapping values, suggesting that further
Figure 2. Temporal variability of the three compounds shown in figure 1 over the nine days of measurements for the eleven
subjects (left). The central mark of each box corresponds to the median, the edges of the box are the 25th and 75th percentiles, the whiskers extend
to the most extreme data points not considered outliers, and outliers are plotted individually (beyond +/–2.7s). The P values resulting from the
Kruskal-Wallis test are quoted on top of the box-plots. Further multicomparison tests (right) showed that, with some exceptions, in most of the cases
inter-subject variability was not significantly different (overlapping intervals).
doi:10.1371/journal.pone.0059909.g002
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multivariate methods are needed to reveal the existence of highly
donor-specific breathprints.
This was done by PCA/CA analysis and the results are
illustrated in figure 3, which shows the projection of the 193
individual mass spectra onto the first 3 PCA/CA dimensions.
Clearly, each subject tends to occupy his/her own space,
suggesting that each individual bears a unique breathprint, which
is stable during at least eleven days (nine workdays + weekend).
The relative contribution of the mass spectral signals to each of the
10 PCA/CA dimensions can be visualized in the loading plots
shown in Supplementary Figure S1. The corresponding mean
signal intensities and 95% confidence intervals of the most
diagnostic signals are listed in Supplementary table S2.
A sharper separation could be obtained by accounting for the
10 canonical dimensions through hierarchical cluster analysis
(Supplementary Figure S2), whereby each of the breath mass
spectra clustered according to donor. Finally, the Kruskal-Wallis/
PCA/CA model was cross validated (n = 11 for test; n = 182 for
model). The inset of Figure 3 summarizes the classification rate
results upon 500 Monte Carlo repartitions. The reddish diagonal
indicates that most of the times the breath mass spectra presented
to the model were correctly assigned to the donor. More precisely,
the overall recognition score was 76%, and the individual correct
classification rate ranged from 62% (subject 11) to 92% (subject 8).
It is interesting to note that, in the former case only 10 samples
were available for this subject. Therefore, at best 9 breath samples
were available in the model during the k-fold cross validation. This
is in line with the learning curves found in Figure 4a of Ref. [8],
were the probability of correct classification with 5 NMR spectra
in model set was around 58% (median of the box plot), 75% for 10
spectra and reached 100% with some 30 spectra. Note also that in
this study we have included samples from different time slots.
Therefore, since diurnal variations in the composition of exhaled
breath are believed to occur [23], this may add further
heterogeneity to the ‘‘characteristic individual fingerprint’’, thus
calling for larger model datasets to cover this intra-day variability.
Overall, this data is consistent with previous work based on
urine showing that small biomolecules released into human
biofluids can be analyzed, and with support of sophisticated
statistical analysis, individual signatures (metabotypes) can be
revealed [8,9]. Moreover, we have included data collected during
different times of the day. It is known that part of the metabolome
fluctuates as a result of biological clocks like for example the
circadian cycle [4]. We found that, despite this potential source of
within day variation, the individual signatures were yet identifi-
able. These results are encouraging; however, one limitation of this
study is the lack of positive identification of most of the breath
components. For this reason, it is difficult to determine to what
extent exogenous compounds (e.g. due to exposure to chemicals in
a laboratory) may ultimately contribute to produce individualized
exhaled fingerprints. Ongoing investigations with a higher
resolving power instrument than the one used in this study are
expected to provide structural elucidation of the most significant
exhaled compounds and therefore ultimately determine to what
extent endogenous metabolites contribute to the individual
breathprints identified in this study. Despite this noted limit-
ation,,this study suggests that breath may be incorporated into
metabolomic studies as a valuable additional source of informa-
tion, complementary to the analysis of other biofluids like plasma
or urine. In addition, even though its analysis in real-time does not
provide sets of information as rich as traditional off-line
techniques, it suffices to track breathprints with individualized
precision. Given that breath analysis is simple, non-invasive and
rapid, we envisage its application as an individualized screening
Figure 3. Projection of the 193 breath mass spectra onto the first three dimensions obtained by supervised Kruskal-Wallis/PCA/CA.
Grouping according to breath donor (represented by different colors and symbols) becomes apparent. The inset displays the blind classification
results upon a cross-validation (average of 500 Monte Carlo repartitions). The overall breath-mass spectrum to breath-donor recognition score was
76%.
doi:10.1371/journal.pone.0059909.g003
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tool; whereby the deviation of one’s breath signature beyond the
natural ‘‘daily noise’’, may trigger further examinations to
determine the reasons.
Conclusions
Based on real-time mass spectrometric analysis of exhaled
breath of a group of subjects during nine days (up to four
measurements per day), we conclude that: i) the intra- and inter-
subject variability for some compounds detected in breath can
vary relatively widely; ii) despite this intra-individual variations,
stable ‘‘core’’ breathprints, which are highly donor-specific could
be identified; iii) overall, this suggests that breath analysis may
contribute, together with other techniques, towards a future
individualized-oriented healthcare.
Supporting Information
Figure S1 Relative signal contributions to each of the 10 PCA/
CA dimensions found to maximize the separation of the breath-
prints of 11 subjects. Positive (negative) values indicate relatively
increased (decreased) intensities in subjects with positive values in
the corresponding dimension (i.e. reddish color in clustergram;
Figure S1) as compared to those with negative values (i.e. greenish
in clustergram; Figure S1).
(TIF)
Figure S2 Clustergram resulting from hierarchical cluster
analysis for the 10 Kruskal-Wallis/PCA/CA dimensions (rows).
The dendrogram on the top displays 11 clusters corresponding
each to one individual (color coded; M: Male; F: Female). The
heatmap provides an overview of the relative contribution of each
of the 10 dimensions to each individual cluster (red: positive
values; black: values close to zero; green: negative values). Intra-
subject distances are smaller than inter-subject ones, suggesting the
existence of individual breath phenotypes.
(TIF)
Table S1 Characteristics of this study subjects.
(DOCX)
Table S2 Mean signal intensities and 95% confidence interval
for the mean (in parentheses) for the most diagnostic ions (i.e.
higher absolute global loading coefficients). The p-values reported
for each m/z were computed according to a Kruskal-Wallis test.
(DOCX)
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